Swarthmore, PA, United States of America

Ronen Marmorstein

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2012-2016

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ronen Marmorstein: Innovator in Molecular Modulation

Introduction

Ronen Marmorstein is a distinguished inventor based in Swarthmore, PA (US). He has made significant contributions to the field of molecular biology, particularly in the development of small molecule treatments for diseases associated with viral oncoproteins. With a total of 5 patents, Marmorstein's work has the potential to impact therapeutic strategies for various conditions.

Latest Patents

Marmorstein's latest patents include innovative approaches to modulating pRb inactivation and p300/CBP activity. One of his notable inventions is a small molecule treatment targeting diseases caused by viruses carrying oncoproteins, such as HPV. This invention involves thiadiazolin-3,5-dione compounds that can be administered alongside compounds inhibiting the binding of HPV E6 to p53. Another significant patent focuses on identifying compounds that modulate the activity of p300/CBP, which are crucial in various cellular processes. This method includes designing or screening compounds that bind to specific sites within the HAT domain of p300/CBP.

Career Highlights

Throughout his career, Marmorstein has worked with reputable institutions, including The Wistar Institute and The Wistar Institute of Anatomy & Biology. His research has been pivotal in advancing our understanding of molecular interactions and their implications in disease treatment.

Collaborations

Marmorstein has collaborated with notable colleagues, including Xin Liu and Philip A. Cole. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Ronen Marmorstein's contributions to molecular biology and his innovative patents position him as a key figure in the field. His work continues to pave the way for new therapeutic approaches to combat diseases linked to viral oncoproteins and cellular regulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…